Vertex Pharmaceuticals (VRTX) Other financing activities (2012 - 2026)
Vertex Pharmaceuticals' quarterly Other financing activities came in at -$400000.0 in Q1 2026, up 20.0% year-on-year from -$333333.3 in Q1 2025, and down 136.36% quarter-over-quarter from $1.1 million in Q4 2025.
Vertex Pharmaceuticals has reported Other financing activities for 15 years, with the latest figure at -$400000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 20.0% year-over-year to -$400000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 72.73% YoY), and the FY2025 full-year result was $3.7 million, down 40.32% from the prior year.
- Other financing activities for Q1 2026 stood at -$400000.0, down from $1.1 million in the prior quarter.
- The five-year high for Other financing activities was $3.5 million in Q1 2024, with the low at -$1.5 million in Q4 2023.
- Average Other financing activities over 5 years is $870588.2, with a median of $1.1 million recorded in 2022.
- Year-over-year, Other financing activities plunged 236.36% in 2023 and surged 218.18% in 2024.
- Tracing VRTX's Other financing activities over 5 years: stood at $1.1 million in 2022, then sank by 236.36% to -$1.5 million in 2023, then soared by 160.0% to $900000.0 in 2024, then increased by 22.22% to $1.1 million in 2025, then sank by 136.36% to -$400000.0 in 2026.
- The last three Other financing activities figures came in at -$400000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -400,000.00 |
| Mar 31, 2026 | -400,000.00 |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.30 Mn |
| Dec 31, 2020 | 2.60 Mn |
| Dec 31, 2020 | 2.60 Mn |
| Sep 30, 2020 | -6.11 Mn |
| Sep 30, 2020 | -6.11 Mn |
| Jun 30, 2020 | 87,000.00 |
| Jun 30, 2020 | 87,000.00 |
| Mar 31, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.62 Mn |
| Dec 31, 2019 | 5.93 Mn |
| Dec 31, 2019 | 5.93 Mn |
| Sep 30, 2019 | -1.13 Mn |
| Sep 30, 2019 | -1.13 Mn |
| Dec 31, 2018 | 3.08 Mn |
| Dec 31, 2018 | 3.08 Mn |
| Sep 30, 2018 | -851,000.00 |
| Sep 30, 2018 | -851,000.00 |
| Jun 30, 2018 | 851,000.00 |
| Jun 30, 2018 | 851,000.00 |
| Mar 31, 2018 | -1.00 Mn |
| Mar 31, 2018 | -1.00 Mn |
| Sep 30, 2017 | 238,000.00 |
| Sep 30, 2017 | 238,000.00 |
| Jun 30, 2017 | -121,000.00 |
| Jun 30, 2017 | -121,000.00 |
| Mar 31, 2017 | -117,000.00 |
| Mar 31, 2017 | -117,000.00 |
| Dec 31, 2016 | -13.33 Mn |
| Dec 31, 2016 | -13.33 Mn |
| Sep 30, 2016 | 5.79 Mn |
| Sep 30, 2016 | 5.79 Mn |
| Jun 30, 2016 | 3.50 Mn |
| Jun 30, 2016 | 3.50 Mn |
| Mar 31, 2016 | 4.04 Mn |
| Mar 31, 2016 | 4.04 Mn |
| Dec 31, 2015 | -16.52 Mn |
| Dec 31, 2015 | -16.52 Mn |
| Sep 30, 2015 | 2.07 Mn |
| Sep 30, 2015 | 2.07 Mn |
| Jun 30, 2015 | 9.94 Mn |
| Jun 30, 2015 | 9.94 Mn |
| Mar 31, 2015 | 4.50 Mn |
| Mar 31, 2015 | 4.50 Mn |
| Dec 31, 2014 | -17.22 Mn |
| Dec 31, 2014 | -17.22 Mn |
| Sep 30, 2014 | 5.33 Mn |
| Sep 30, 2014 | 5.33 Mn |
| Jun 30, 2014 | 3.83 Mn |
| Jun 30, 2014 | 3.83 Mn |
| Mar 31, 2014 | 8.05 Mn |
| Mar 31, 2014 | 8.05 Mn |
| Dec 31, 2013 | 61.99 Mn |
| Dec 31, 2013 | 61.99 Mn |
| Sep 30, 2013 | -63.24 Mn |
| Sep 30, 2013 | -63.24 Mn |
| Jun 30, 2013 | 17.71 Mn |
| Jun 30, 2013 | 17.71 Mn |
| Mar 31, 2013 | -17.71 Mn |
| Mar 31, 2013 | -17.71 Mn |
| Dec 31, 2012 | 8.24 Mn |
| Dec 31, 2012 | 8.24 Mn |
| Sep 30, 2012 | -7.49 Mn |
| Sep 30, 2012 | -7.49 Mn |
| Jun 30, 2012 | 1.21 Mn |
| Jun 30, 2012 | 1.21 Mn |